We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCOV
1651
DELISTED
Brightcove, Inc.
BCOV
| $367K | ﹤0.01% |
+35,871
| New | +$358K |
|
1652
CALL
JPMorgan Chase
JPM
$939B
| $366K | ﹤0.01% |
3,800
| – | – |
|
|
1653
PUT
JPMorgan Chase
JPM
$939B
| $366K | ﹤0.01% |
3,800
| – | – |
|
1654
Northern Oil and Gas
NOG
$2.3B
| $366K | ﹤0.01% |
63,814
+15,847
| +33% | +$113K |
|
|
GLOG
1655
DELISTED
GASLOG LTD
GLOG
| $366K | ﹤0.01% |
135,119
+19,685
| +17% | +$59.8K |
|
1656
Dolby
DLB
$4.72B
| $365K | ﹤0.01% |
+5,510
| New | +$373K |
|
|
FPRX
1657
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $365K | ﹤0.01% |
77,624
+58,460
| +305% | +$297K |
|
|
SWTX
1658
DELISTED
SpringWorks Therapeutics
SWTX
| $364K | ﹤0.01% |
7,643
-8,411
| -52% | -$358K |
|
1659
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.4B
| $364K | ﹤0.01% |
4,952
-18,530
| -79% | -$1.31M |
|
1660
BellRing Brands
BRBR
$1.51B
| $363K | ﹤0.01% |
+17,499
| New | +$344K |
|
1661
Stoke Therapeutics
STOK
$1.82B
| $363K | ﹤0.01% |
+10,837
| New | +$309K |
|
1662
Invesco Mortgage Capital
IVR
$776M
| $362K | ﹤0.01% |
13,354
+11,852
| +789% | +$365K |
|
1663
Belden
BDC
$4B
| $361K | ﹤0.01% |
11,587
-444
| -4% | -$14.6K |
|
1664
Hyster-Yale Materials Handling
HY
$593M
| $361K | ﹤0.01% |
+9,724
| New | +$383K |
|
1665
Plains GP Holdings
PAGP
$5.23B
| $360K | ﹤0.01% |
+59,054
| New | +$452K |
|
1666
Photronics
PLAB
$1.79B
| $360K | ﹤0.01% |
36,188
-7,211
| -17% | -$77.9K |
|
|
CHX
1667
DELISTED
ChampionX
CHX
| $359K | ﹤0.01% |
+44,902
| New | +$433K |
|
1668
CALL
T. Rowe Price
TROW
$25B
| $359K | ﹤0.01% |
+2,800
| New | +$370K |
|
|
1669
PUT
T. Rowe Price
TROW
$25B
| $359K | ﹤0.01% |
+2,800
| New | +$370K |
|
1670
UBS Group
UBS
$170B
| $359K | ﹤0.01% |
32,199
+4,425
| +16% | +$53K |
|
|
ITI
1671
DELISTED
Iteris, Inc.
ITI
| $359K | ﹤0.01% |
87,440
-7,311
| -8% | -$33.9K |
|
1672
Levi Strauss
LEVI
$9.44B
| $358K | ﹤0.01% |
+26,700
| New | +$339K |
|
1673
M/I Homes
MHO
$3.83B
| $358K | ﹤0.01% |
+7,784
| New | +$324K |
|
1674
Cardlytics
CDLX
$21M
| $356K | ﹤0.01% |
+505
| New | +$367K |
|
1675
Hope Bancorp
HOPE
$1.72B
| $356K | ﹤0.01% |
46,884
-58,116
| -55% | -$486K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.